Search results

In modern biologics development, the ability to generate truly novel and differentiated therapeutic candidates has become a defining factor for success. As pharmaceutical pipelines become more competitive, organizations are increasingly focused on designing antibody molecules that are not only...

Advances in biologics have significantly expanded the possibilities of therapeutic design, particularly in the field of multi-specific antibody formats. Among these, trispecific antibodies represent a powerful evolution, enabling simultaneous targeting of three distinct antigens or epitopes...